Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disease-modifying effects of metabolic perturbations in ALS/FTLD
Ali Jawaid, Romesa Khan, Magdalini Polymenidou, et al.
Molecular Neurodegeneration (2018) Vol. 13, Iss. 1
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Stephen C. Cunnane, Eugenia Trushina, Cecilie Morland, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 9, pp. 609-633
Open Access | Times Cited: 689
Neurotoxicity of polychlorinated biphenyls and related organohalogens
Isaac N. Pessah, Pamela J. Lein, Richard F. Seegal, et al.
Acta Neuropathologica (2019) Vol. 138, Iss. 3, pp. 363-387
Open Access | Times Cited: 177
Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry
Yaping Shao, Tianbai Li, Zheyi Liu, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 153
Nicotinamide Riboside Enhances Mitochondrial Proteostasis and Adult Neurogenesis through Activation of Mitochondrial Unfolded Protein Response Signaling in the Brain of ALS SOD1G93A Mice
Qi Zhou, Lei Zhu, Weiwen Qiu, et al.
International Journal of Biological Sciences (2019) Vol. 16, Iss. 2, pp. 284-297
Open Access | Times Cited: 66
Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer’s disease
Tahir Ali, Shafiq Ur Rehman, Amjad Khan, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 48
Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration
Audrey Labarre, Ericka Guitard, Gilles Tossing, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 34
Improvement in Zebrafish with Diabetes and Alzheimer's Disease Treated with Pasteurized Akkermansia muciniphila
Linkai Qu, Fan Liu, Yimeng Fang, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 20
Western Pacific ALS-PDC: Evidence implicating cycad genotoxins
Peter S. Spencer, Valerie S. Palmer, Glen E. Kisby
Journal of the Neurological Sciences (2020) Vol. 419, pp. 117185-117185
Closed Access | Times Cited: 42
Mitochondrial dysregulation occurs early in ALS motor cortex with TDP-43 pathology and suggests maintaining NAD+ balance as a therapeutic strategy
Mukesh Gautam, Aksu Günay, Navdeep S. Chandel, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Activation of the Mitochondrial Unfolded Protein Response: A New Therapeutic Target?
Juan M. Suárez-Rivero, Carmen J. Pastor‐Maldonado, Suleva Povea-Cabello, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1611-1611
Open Access | Times Cited: 24
From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline
Rajka M. Liščić, Antonella Alberici, Nigel J. Cairns, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 37
Neuroprotective Effect of a Multistrain Probiotic Mixture in SOD1G93A Mice by Reducing SOD1 Aggregation and Targeting the Microbiota-Gut-Brain Axis
Zikai Xin, Cheng Xin, Jia Huo, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10051-10071
Open Access | Times Cited: 5
Higher Glycemic Index and Glycemic Load Diet Is Associated with Slower Disease Progression in Amyotrophic Lateral Sclerosis
Ikjae Lee, Hiroshi Mitsumoto, Seonjoo Lee, et al.
Annals of Neurology (2023) Vol. 95, Iss. 2, pp. 217-229
Open Access | Times Cited: 10
Association Between Atg5-independent Alternative Autophagy and Neurodegenerative Diseases
Shinya Honda, Satoko Arakawa, Hirofumi Yamaguchi, et al.
Journal of Molecular Biology (2020) Vol. 432, Iss. 8, pp. 2622-2632
Closed Access | Times Cited: 24
The hypometabolic state: a good predictor of a better prognosis in amyotrophic lateral sclerosis
Marina Cattaneo, Pierre Jésus, Andrea Lizio, et al.
Journal of Neurology Neurosurgery & Psychiatry (2021) Vol. 93, Iss. 1, pp. 41-47
Closed Access | Times Cited: 21
TDP-43 regulates cholesterol biosynthesis by inhibiting sterol regulatory element-binding protein 2
Naohiro Egawa, Yuishin Izumi, Hidefumi Suzuki, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Type II diabetes mellitus and the incidence of amyotrophic lateral sclerosis
Ching-Piao Tsai, Johnny Kuang-Wu Lee, Charles Tzu‐Chi Lee
Journal of Neurology (2019) Vol. 266, Iss. 9, pp. 2233-2243
Closed Access | Times Cited: 24
Curcumin inhibits liquid–liquid phase separation of fused in sarcoma and attenuates the sequestration of pyruvate kinase to restore cellular metabolism
Wen‐Pu Shi, W. Lin, Wan‐Yi Ge, et al.
Food & Function (2023) Vol. 14, Iss. 10, pp. 4621-4631
Closed Access | Times Cited: 7
Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study
Charilaos Chourpiliadis, Christina Seitz, Anikó Lovik, et al.
Journal of Neurology (2024) Vol. 271, Iss. 8, pp. 5447-5459
Open Access | Times Cited: 2
Prognostic analysis of amyotrophic lateral sclerosis based on clinical features and plasma surface‐enhanced Raman spectroscopy
Qi‐Jie Zhang, Yang Chen, Xiaohuan Zou, et al.
Journal of Biophotonics (2019) Vol. 12, Iss. 8
Closed Access | Times Cited: 16
Using Mendelian randomization to understand and develop treatments for neurodegenerative disease
Catherine S. Storm, Demis A. Kia, Mona Mohammad Almramhi, et al.
Brain Communications (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 15
Trends in Understanding the Pathological Roles of TDP-43 and FUS Proteins
Emanuele Buratti
Advances in experimental medicine and biology (2021), pp. 243-267
Closed Access | Times Cited: 13
Diabetes mellitus is associated with a lower risk of amyotrophic lateral sclerosis: A systematic review and meta-analysis
Thapat Wannarong, Patompong Ungprasert
Clinical Neurology and Neurosurgery (2020) Vol. 199, pp. 106248-106248
Closed Access | Times Cited: 11
Metabolic Disturbances in a Mouse Model of MPTP/Probenecid-Induced Parkinson’s Disease: Evaluation Using Liquid Chromatography-Mass Spectrometry
Yueyuan Wang, Bo Lv, Kai Fan, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 1629-1639
Open Access | Times Cited: 1
Diabetes Mellitus and Amyotrophic Lateral Sclerosis: A Systematic Review
Laura Ferri, Paola Ajdinaj, Marianna Gabriella Rispoli, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 867-867
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top